Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010

Share Name	Share Symbol	Market	Type
Valeant Pharmaceuticals International, Inc.	AMEX:VRX	AMEX	Common Stock

Share Name

Share Symbol

Market

Type

Valeant Pharmaceuticals International, Inc.

AMEX:VRX

AMEX

Common Stock

Price Change

% Change

Share Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010

08/02/2010 1:00pm

PR Newswire (US)

Valeant Pharmaceuticals International, Inc. (AMEX:VRX)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Valeant Pharmaceuticals International, Inc. Charts.

ALISO VIEJO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Monday, February 22, 2010 at 10:00 a.m. EST (7:00 a.m. PST) to discuss results for the 2009 fourth quarter and year. The dial-in number to participate on this call is (877) 295-5743, confirmation code 53708100. International callers should dial (973) 200-3961, confirmation code 53708100. A replay will be available approximately two hours following the conclusion of the conference call to Monday, March 1, 2010, and can be accessed by dialing (800) 642-1687 or (706) 645-9291, confirmation code 53708100. The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at http://www.valeant.com/. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at http://www.valeant.com/. About Valeant Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at http://www.valeant.com/. Contact: Laurie W. Little 949-461-6002 (Logo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO) http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO http://photoarchive.ap.org/ DATASOURCE: Valeant Pharmaceuticals International CONTACT: Laurie W. Little of Valeant Pharmaceuticals International, +1-949-461-6002, Web Site: http://www.valeant.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

VRX Valeant Pharmaceuticals International, Inc.